Assessment of the Effectiveness of Menopur in Intrauterine Insemination

Ferring Pharmaceuticals207 enrolled

Overview

The purpose of this study is to assess the effectiveness of Menopur to achieve clinical pregnancy in females undergoing intrauterine insemination in clinical practice.

Study Type

OBSERVATIONAL

Enrollment

207

Conditions

Infertility

Interventions

hMGDRUG

Patients with a condition

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Infertile couples for over one year (primary or secondary) or infertile women (or not) with indication of PAI or DAI * Seminal sample suitable for artificial insemination treatment according to the criterion of each centre * Patient prescribed therapy with Menopur in artificial insemination Exclusion Criteria: * Contraindications to intrauterine insemination * Contraindications to Menopur

Locations (14)

Investigational site

Elche, Alicante, Spain

Investigational site

Las Palmas, Grand Canaria, Spain

Investigational site

Santiago, La Coruña, Spain

Outcomes

Primary Outcomes

Clinical pregnancy rate

Time frame: 30 days

Secondary Outcomes

Live birth rate

Time frame: 40 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.